Literature DB >> 24196348

In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy.

Fei Du1, Alissa J Cooper2, Thida Thida2, Selma Sehovic2, Scott E Lukas3, Bruce M Cohen4, Xiaoliang Zhang5, Dost Ongür1.   

Abstract

IMPORTANCE: Abnormalities in neural activity and cerebral bioenergetics have been observed in schizophrenia (SZ). Further defining energy metabolism anomalies would provide crucial information about molecular mechanisms underlying SZ and may be valuable for developing novel treatment strategies.
OBJECTIVE: To investigate cerebral bioenergetics in SZ via measurement of creatine kinase activity using in vivo 31P magnetization transfer spectroscopy. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional case-control study in the setting of clinical services and a brain imaging center of an academic psychiatric hospital. Twenty-six participants with chronic SZ (including a subgroup diagnosed as having schizoaffective disorder) and 26 age-matched and sex-matched healthy control subjects (25 usable magnetic resonance spectroscopy data sets from the latter). INTERVENTION: 31P magnetization transfer spectroscopy. MAIN OUTCOMES AND MEASURES: The primary outcome measure was the forward rate constant (k(f)) of the creatine kinase enzyme in the frontal lobe. We also collected independent measures of brain intracellular pH and steady-state metabolite ratios of high-energy phosphate-containing compounds (phosphocreatine and adenosine triphosphate [ATP]), inorganic phosphate, and the 2 membrane phospholipids phosphodiester and phosphomonoester.
RESULTS: A substantial (22%) and statistically significant (P = .003) reduction in creatine kinase kf was observed in SZ. In addition, intracellular pH was significantly reduced (7.00 in the SZ group vs 7.03 in the control group, P = .007) in this condition. The phosphocreatine to ATP ratio, inorganic phosphate to ATP ratio, and phosphomonoester to ATP ratio were not substantially altered in SZ, but a significant (P = .02) reduction was found in the phosphodiester to ATP ratio. The abnormalities were similar between SZ and schizoaffective disorder. CONCLUSIONS AND RELEVANCE: Using a novel 31P magnetization transfer magnetic resonance spectroscopy approach, we provide direct and compelling evidence for a specific bioenergetic abnormality in SZ. Reduced kf of the creatine kinase enzyme is consistent with an abnormality in storage and use of brain energy. The intracellular pH reduction suggests a relative increase in the contribution of glycolysis to ATP synthesis, providing convergent evidence for bioenergetic abnormalities in SZ. The similar phosphocreatine to ATP ratios in SZ and healthy controls suggest that the underlying bioenergetics abnormality is not associated with change in this metabolite ratio.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24196348     DOI: 10.1001/jamapsychiatry.2013.2287

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  37 in total

1.  Decreased brain PME/PDE ratio in bipolar disorder: a preliminary (31) P magnetic resonance spectroscopy study.

Authors:  Xian-Feng Shi; Paul J Carlson; Young-Hoon Sung; Kristen K Fiedler; Lauren N Forrest; Tracy L Hellem; Rebekah S Huber; Seong-Eun Kim; Chun Zuo; Eun-Kee Jeong; Perry F Renshaw; Douglas G Kondo
Journal:  Bipolar Disord       Date:  2015-10-19       Impact factor: 6.744

2.  Cancer Immune Equilibrium and Schizophrenia Have Similar Interferon-γ, Tumor Necrosis Factor-α, and Interleukin Expression: A Tumor Model of Schizophrenia.

Authors:  James S Brown
Journal:  Schizophr Bull       Date:  2016-05-11       Impact factor: 9.306

3.  Brain cytochrome-c-oxidase as a marker of mitochondrial function: A pilot study in major depression using NIRS.

Authors:  Lisa Holper; Martin J Lan; Patrick J Brown; Elizabeth M Sublette; Ainsley Burke; John J Mann
Journal:  Depress Anxiety       Date:  2019-05-21       Impact factor: 6.505

Review 4.  Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia: Possible Interactions with Cellular Processes.

Authors:  Oded Bergman; Dorit Ben-Shachar
Journal:  Can J Psychiatry       Date:  2016-08       Impact factor: 4.356

5.  Rapporteur summaries of plenary, symposia, and oral sessions from the XXIIIrd World Congress of Psychiatric Genetics Meeting in Toronto, Canada, 16-20 October 2015.

Authors:  Gwyneth Zai; Bonnie Alberry; Janine Arloth; Zsófia Bánlaki; Cristina Bares; Erik Boot; Caroline Camilo; Kartikay Chadha; Qi Chen; Christopher B Cole; Katherine T Cost; Megan Crow; Ibene Ekpor; Sascha B Fischer; Laura Flatau; Sarah Gagliano; Umut Kirli; Prachi Kukshal; Viviane Labrie; Maren Lang; Tristram A Lett; Elisabetta Maffioletti; Robert Maier; Marina Mihaljevic; Kirti Mittal; Eric T Monson; Niamh L O'Brien; Søren D Østergaard; Ellen Ovenden; Sejal Patel; Roseann E Peterson; Jennie G Pouget; Diego L Rovaris; Lauren Seaman; Bhagya Shankarappa; Fotis Tsetsos; Andrea Vereczkei; Chenyao Wang; Khethelo Xulu; Ryan K C Yuen; Jingjing Zhao; Clement C Zai; James L Kennedy
Journal:  Psychiatr Genet       Date:  2016-12       Impact factor: 2.458

6.  Abnormal high-energy phosphate molecule metabolism during regional brain activation in patients with bipolar disorder.

Authors:  C Yuksel; F Du; C Ravichandran; J R Goldbach; T Thida; P Lin; B Dora; J Gelda; L O'Connor; S Sehovic; S Gruber; D Ongur; B M Cohen
Journal:  Mol Psychiatry       Date:  2015-03-10       Impact factor: 15.992

Review 7.  Imaging and spectroscopic approaches to probe brain energy metabolism dysregulation in neurodegenerative diseases.

Authors:  Gilles Bonvento; Julien Valette; Julien Flament; Fanny Mochel; Emmanuel Brouillet
Journal:  J Cereb Blood Flow Metab       Date:  2017-03-09       Impact factor: 6.200

Review 8.  The bimodal mechanism of interaction between dopamine and mitochondria as reflected in Parkinson's disease and in schizophrenia.

Authors:  Dorit Ben-Shachar
Journal:  J Neural Transm (Vienna)       Date:  2019-12-17       Impact factor: 3.575

Review 9.  Defects in Bioenergetic Coupling in Schizophrenia.

Authors:  Courtney R Sullivan; Sinead M O'Donovan; Robert E McCullumsmith; Amy Ramsey
Journal:  Biol Psychiatry       Date:  2017-10-24       Impact factor: 13.382

10.  Redox Dysregulation in Schizophrenia Revealed by in vivo NAD+/NADH Measurement.

Authors:  Sang-Young Kim; Bruce M Cohen; Xi Chen; Scott E Lukas; Ann K Shinn; A Cagri Yuksel; Tao Li; Fei Du; Dost Öngür
Journal:  Schizophr Bull       Date:  2016-09-24       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.